Health Condition 1: K35-K38- Diseases of appendix Health Condition 2: H65-H75- Diseases of middle ear and mastoid Health Condition 3: K80-K87- Disorders of gallbladder, biliary tract and pancreas Health Condition 4: K40-K46- Hernia Health Condition 5: C73-C75- Malignant neoplasms of thyroid and other endocrine glands
Conditions
Interventions
Intervention1: DOSAGE ADJUSTMENT OF DRUG: in our study,we will be applying â??Priming principleâ??
a subanaesthetic dose administration of propofol, with the aim of reducing the induction dose requirement and hence, better haemodynamic stability following induction.
Intervention2: PRIMING DOSE OF P
30% OF THE CALCULATED DOSE IS TAKEN AS THE PRIMING DOSE IN OUR STUDY.
THEN THE REMAINING DOSE WILL BE GIVEN AFTER TWO MINUTES BASED ON THE LOSS OF VERBAL RESPONSE OF THE PATIENT.
total calculated dos
Sponsors
REEHANA JABARULLA
Eligibility
Inclusion criteria
Inclusion criteria: ASA 1 and 2
Exclusion criteria
Exclusion criteria: H/O allergy to egg, opioids Alcoholics H/O intake of CNS depressants ASA 3 and 4 Haemodynamic instability BMI > 35 Anticipated difficult intubation Pregnancy and lactating mothers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To Study the Effect of Priming Principle on the Induction dose requirement of Propofol.Timepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| To Compare the Hemodynamics between the group in which Priming Principle was applied and the group in which No priming was applied. Timepoint: 1 year | — |
Countries
India
Contacts
Public ContactR KAVITHA
PSGIMSR
Outcome results
None listed